Patients with irritable bowel syndrome who follow individualized diets based on food sensitivity testing experience fewer symptoms, say Yale researchers.
An international Yale-led research team has shown that a risk profile based on 52 genes accurately predicts survival for patients with a severe lung disease.
Faculty can receive funding and support to turn their research into commercial opportunity as the Blavatnik Fund for Innovation at Yale enters its second year.
On Sept. 11, Yale's Treatment Action Group and the Global Health Justice Partnership won an important legal victory for clinical research transparency.
Scientists have uncovered two molecules involved in cell communication and movement that may explain why some people develop progressive multiple sclerosis.
